Perspective on Cancer Therapeutics Utilizing Analysis of Circulating Tumor Cells

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Cancer screening and treatment selection rely on various methods, with biopsy and imaging being common.
• Circulating tumor cells (CTCs) offer a novel approach for monitoring cancer progression and treatment response.

Purpose of the Study:

• To highlight the potential of a new assay for detecting and characterizing circulating tumor cells (CTCs).
• To emphasize the importance of CTC analysis for personalized cancer therapy and clinical decision-making.

Main Methods:

• Development of a new assay for detecting circulating tumor cells (CTCs).
• Characterization of CTCs at the DNA, RNA, and protein levels.
• Analysis of CTCs for genomic information, including cancer progression and metastasis.

Main Results:

• Tracking CTC changes may reveal tumoral sensitivity or resistance patterns.
• CTC analysis can provide genome information even from a small number of cells.
• Current studies show increased diagnostic success and prognostic prediction through CTC enumeration and oncogene expression detection.

Conclusions:

• Standardization of CTC analysis methods is challenging due to a lack of consensus.
• Ongoing technological advancements and large-scale studies are crucial for clinical application.
• CTC analysis holds significant potential for advancing cancer diagnosis, prognosis prediction, and therapeutics.